Antibody–drug conjugates (ADCs) are an anticancer therapy utilizing an antibody to carry a cytotoxic molecule directly to a tumour, thus avoiding the systemic side effects that can occur when non-targeted anticancer agents are administered systemically. Today, we recognize ADCs as being comprised of...